2017, Number 08
<< Back Next >>
Ginecol Obstet Mex 2017; 85 (08)
Risk factors associated with increased progesterone on the day of hCG application in stimulation protocols with an antagonist for in vitro fertilization
Carballo-Mondragón E, Roque-Sánchez AM, Soriano-Ortega KP, Durán-Monterrosas L, Kably-Ambe A
Language: Spanish
References: 10
Page: 525-530
PDF size: 196.93 Kb.
ABSTRACT
Background: It is well known that premature luteinization has a deletereous efecto on the outcome of IVF cycles however there are no reports that evaluate associated risk factor.
Objetive: To evaluate factors associated to premature luteinization during folicular phase of IVF cycles under antagonist stimulation protocol.
Material and Method: This is a comparative, retrospective, observational study. 469 IVF flexible-antagonist protocol cycles were included from January 2009 to February 2014.
Results: We registered 469 IVF cycles. The IMC, basal estradiol, age and estradiol on trigger date showed correlation with premature luteinization. There were no association with basal FSH and LH nor total gonadotropin dose.
Conclusion: Lowe age and IMC and higher estradio levels are associated to a higer level of progesterone on trigger date.
REFERENCES
Lee VC, Li RH, Chai J, Yeung TW, Yeung WS, et al. Effect of preovulatory progesterone elevation and duration of progesterone elevation on the pregnancy rate of frozen-thawed embryo transfer in natural cycles. Fertil Steril. 2014;101(5):1288-93.
Van Vaerenbergh I, Fatemi H, Blockeel C, Van Lommel L, In't Veld P, Schuit F, et al. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online 2011;22:263-71.
Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is P elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007; 13:343-55.
Li R, Qiao J, Wang L, Zhen X, Lu Y. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Biomed Online 2008;16:627-31.
Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, et al. Progesterone rise on the day of human chorionic gonad- otropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril 2009;91:949-52.
Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM: The Science behind 25 years of Ovarian Stimulation for In Vitro Fertilization. Endocr Rev 2006;27(2):170-207.
Fleming R, Jenkins J. The source and implications of progesterone rise during the follicular phase of assisted reproduction cycle. Reprod Biomed Online. 2010;21(4):446-9.
Huang CC, Lien YR, Chen HF, Chen MJ, Shieh CJ, Yao YL, et al. The duration of pre- ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles. Hum Reprod 2012;27:2036-45.
Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010;25:2092-100.
Fanchin R, Righini C, Olivennes F, De Ziegler D, Selva J, Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 1996;65:1178-83.